Terms ending in 2036
Every in-force patent on The Institut Pasteur's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,000,521 | Dipeptidylpeptidase 4 Inhibition Enhances Lymphocyte Trafficking, Improving Both Naturally Occurring Tumor Immunity and Immunotherapy In force · High confidence | Institut Pasteur and Institut National de la Sante et de la Recherche Medicale (Inserm) | In force | High confidence | |
| US 10,206,994 | RNA Virus Attenuation by Alteration of Mutational Robustness and Sequence Space In force · High confidence | Institut Pasteur | In force | High confidence | |
| US 10,591,466 | New in Vitro Blood-Brain Barrier Model In force · High confidence | Institut Pasteur and Institut National de la Sante et de la Recherche Medicale | In force | High confidence | |
| US 10,751,385 | Prevention And/Or Treatment of Hearing Loss or Impairment In force · High confidence | Sorbonne Universite | In force | High confidence | |
| US 10,525,117 | Leptospira Immunoprotective Proteins and Methods of Identification and Use Thereof In force · High confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | High confidence | |
| US 11,198,706 | Anti-Dengue Vaccines and Antibodies In force · High confidence | Institut Pasteur | In force | High confidence | |
| US 10,703,801 | Antibodies That Potently Neutralize Rabies Virus and Other Lyssaviruses and Uses Thereof In force · High confidence | Humabs Biomed S.A. | In force | High confidence | |
| US 10,493,046 | 5-Hydroxytryptamine 1B Receptor-Stimulating Agent for Use as a Promoter of Satellite Cells Self-Renewal And/Or Differentiation In force · High confidence | Université Paris Cité | In force | High confidence | |
| US 11,618,781 | Polyclonal Antibodies Specific for Serogroup X of N. Meningitidis and Uses Thereof in Diagnosis In force · Medium confidence | Institut Pasteur | In force | Medium confidence | |
| US 11,679,140 | Prevention And/Or Treatment of Hearing Loss or Impairment In force · Medium confidence | Centre National de la Recherche Scientifique (CNRS) | In force | Medium confidence | |
| 10 more term ends in 2036 · Pro | |||||
10 of 20 patents shown. Soonest term end first, then patent number.
Pro members see all 20.
15 of these are in force and held by The Institut Pasteur.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.